(+)-Tazettine

ID: ALA457605

Cas Number: 507-79-9

PubChem CID: 5321780

Max Phase: Preclinical

Molecular Formula: C18H21NO5

Molecular Weight: 331.37

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Synonyms: (+)-Tazettine | Tazettine|Sekisanolin|Sekisanoline|Ungernine|(+)-Tazettine|Sekisanin|UNII-76WEU12CSO|76WEU12CSO|Tazetine|Tazettin|Ungernin|507-79-9|CHEBI:32185|NSC 652297|Sekisanine|NSC 115495|(1S,13S,16S,18S)-18-methoxy-15-methyl-5,7,12-trioxa-15-azapentacyclo[11.7.0.01,16.02,10.04,8]icosa-2,4(8),9,19-tetraen-13-ol|NSC-115495|NSC-652297|TACETTINE|TAZETTINE [MI]|CHEMBL457605|SCHEMBL5792215|DTXSID10878333|8H-(1,3)DIOXOLO(6,7)(2)BENZOPYRANO(3,4-C)INDOL-6A(3H)-OL, 4,4A,5,6-TETRAHYDRO-3-METHOXY-5-MEShow More

Canonical SMILES:  CO[C@@H]1C=C[C@@]23c4cc5c(cc4CO[C@]2(O)CN(C)[C@H]3C1)OCO5

Standard InChI:  InChI=1S/C18H21NO5/c1-19-9-18(20)17(4-3-12(21-2)6-16(17)19)13-7-15-14(22-10-23-15)5-11(13)8-24-18/h3-5,7,12,16,20H,6,8-10H2,1-2H3/t12-,16+,17+,18-/m1/s1

Standard InChI Key:  YLWAQARRNQVEHD-PBZHRCKQSA-N

Molfile:  

     RDKit          2D

 25 29  0  0  0  0  0  0  0  0999 V2000
   -0.7654   -2.0716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0550   -1.6546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0609   -0.8353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7757   -0.4270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4861   -0.8440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4818   -1.6695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1957   -3.7383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1977   -2.0850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9087   -3.3255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9073   -2.4963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6954   -2.2388    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1840   -2.9088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6976   -3.5804    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4795   -2.4939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4805   -3.3275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7630   -3.7429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0399   -3.3290    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0390   -2.4955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7700   -1.6546    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7838   -2.4934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3486   -1.0664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5271   -1.0679    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.5409   -3.0754    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7806    0.3980    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0685    0.8147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13  9  1  0
 14 15  1  0
  9  7  1  0
  7 15  2  0
  1  2  1  0
 14  8  2  0
  1 14  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18  1  1  0
  8 10  1  0
  2 19  1  0
  9 10  2  0
 18 20  1  0
 20 19  1  0
  1  6  1  6
 19 21  1  0
  2  3  1  0
  2 22  1  1
  3  4  1  0
 18 23  1  6
  4  5  1  0
  4 24  1  1
  5  6  2  0
 24 25  1  0
M  END

Alternative Forms

  1. Parent:

    ALA457605

    TAZETTINE

Associated Targets(Human)

A-431 (6446 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Col2 (437 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT (265 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KB (17409 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LNCaP (8286 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Lu1 (576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-2 (46422 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ZR-75-1 (953 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL (619 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AKR1C3 Tchem Aldo-keto-reductase family 1 member C3 (1414 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P388 (20296 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
B16-F10 (4610 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trichomonas vaginalis (2376 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 331.37Molecular Weight (Monoisotopic): 331.1420AlogP: 1.16#Rotatable Bonds: 1
Polar Surface Area: 60.39Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.09CX Basic pKa: 7.56CX LogP: 1.28CX LogD: 0.89
Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.78Np Likeness Score: 2.38

References

1. Antoun MD, Mendoza NT, Ríos YR, Proctor GR, Wickramaratne DB, Pezzuto JM, Kinghorn AD..  (1993)  Cytotoxicity of Hymenocallis expansa alkaloids.,  56  (8): [PMID:8229020] [10.1021/np50098a030]
2. Kaur K, Jain M, Kaur T, Jain R..  (2009)  Antimalarials from nature.,  17  (9): [PMID:19299148] [10.1016/j.bmc.2009.02.050]
3. Van Goietsenoven G, Andolfi A, Lallemand B, Cimmino A, Lamoral-Theys D, Gras T, Abou-Donia A, Dubois J, Lefranc F, Mathieu V, Kornienko A, Kiss R, Evidente A..  (2010)  Amaryllidaceae alkaloids belonging to different structural subgroups display activity against apoptosis-resistant cancer cells.,  73  (7): [PMID:20550100] [10.1021/np9008255]
4. McNulty J, Nair JJ, Little JR, Brennan JD, Bastida J..  (2010)  Structure-activity studies on acetylcholinesterase inhibition in the lycorine series of Amaryllidaceae alkaloids.,  20  (17): [PMID:20655219] [10.1016/j.bmcl.2010.06.130]
5. Luo Z, Wang F, Zhang J, Li X, Zhang M, Hao X, Xue Y, Li Y, Horgen FD, Yao G, Zhang Y..  (2012)  Cytotoxic alkaloids from the whole plants of Zephyranthes candida.,  75  (12): [PMID:23190013] [10.1021/np3005425]
6. Nair JJ, van Staden J..  (2019)  Antiprotozoal alkaloid principles of the plant family Amaryllidaceae.,  29  (20): [PMID:31515186] [10.1016/j.bmcl.2019.126642]
7. Liu Y,He S,Chen Y,Liu Y,Feng F,Liu W,Guo Q,Zhao L,Sun H.  (2020)  Overview of AKR1C3: Inhibitor Achievements and Disease Insights.,  63  (20.0): [PMID:32463235] [10.1021/acs.jmedchem.9b02138]

Source